News

Mission

The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Transfected SARS-CoV-2 Spike DNA Suppresses Cancer Cell Response to Chemotherapy

News

May 6, 2024

PRESS RELEASE: On May 3, 2024, a new research paper was published in Oncotarget, entitled, “Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure.” continue reading »

Exploring Oncogenic Driver Molecular Alterations in Hispanic/Latin American Cancer Patients

News

May 3, 2024

PRESS RELEASE: A new editorial paper was published in Oncoscience on April 22, 2024, entitled, “Exploring oncogenic driver molecular alterations in Hispanic/Latin American cancer patients: A call for enhanced molecular understanding.” continue reading »

A Novel Deep Proteomic Approach Unveils Molecular Signatures Affected by Aging and Resistance Training

Aging

May 1, 2024

PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 8, entitled, “A novel deep proteomic approach in human skeletal muscle unveils distinct molecular signatures affected by aging and resistance training.” continue reading »

Cover Paper: Senescent Characteristics of Human Corneal Endothelial Cells Upon UV-A Exposure

Aging

April 30, 2024

PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 16, Issue 8, entitled, “Senescent characteristics of human corneal endothelial cells upon ultraviolet-A exposure.” continue reading »

Oncotarget Sponsors 19th International p53 Workshop in Italy

News

April 29, 2024

PRESS RELEASE: Oncotarget is a contributing sponsor at the 19th International p53 Workshop in Trieste, Italy, on May 13–16, 2024. continue reading »

« Previous 1 … 25 26 27 28 29 … 102 Next »